The Generics Bulletin Podcast: Stelara Biosimilar Launches In The US

Generics Bulletin editors Dave Wallace and Dean Rudge discuss the latest updates on Stelara (ustekinumab) biosimilars in the US, including recent launches, pricing strategies, and parallels with the biosimilar Humira (adalimumab) experience.

Episode metadata supplied by the publisher feed · Published Mar 11, 2025

Embed this episode

Attribution link and audio player

NOW PLAYING

The Generics Bulletin Podcast: Stelara Biosimilar Launches In The US

0:00 17:20

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of Citeline Podcasts?

This episode is 17 minutes long.

When was this Citeline Podcasts episode published?

This episode was published on March 11, 2025.

Can I download this Citeline Podcasts episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!